Ischaemia-reperfusion injury in mouse skeletal muscle is reduced by N(ω)-nitro-L-arginine methyl ester and dexamethasone

European Journal of Pharmacology

Volumn 332, Issue 3, 1997, Pages 273-278

  Knight, Kenneth R ^a   Zhang, Baimeng ^a   Morrison, Wayne A ^a   Stewart, Alastair G ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Ischaemia reperfusion; Mouse; Nitric oxide (NO); Oedema; Skeletal muscle; Viability

Indexed keywords

DEXAMETHASONE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SKELETAL MUSCLE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; DEXAMETHASONE; EDEMA; ENZYME INHIBITORS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NG-NITROARGININE METHYL ESTER; NITROBLUE TETRAZOLIUM; OXIDATIVE PHOSPHORYLATION; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TETRAZOLIUM SALTS;

EID: 0030815189     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01101-1     Document Type: Article

References (29)

1. Belkin M., Brown R.D., Wright J.G., LaMorte W.W., Hobson R.W. II A new quantitative spectrophotometric assay of ischemia-reperfusion injury in skeletal muscle. Am. J. Surg. 156:1988;83-86.
2. Bozeman P.M., Learn D.B., Thomas E.L. Assay of human leukocyte enzymes: Myeloperoxidase and eosinophil peroxidase. J. Immunol. Methods. 126:1990;125-133.
3. Christiansen D., Milland J., Thorley B.R., McKenzie I.F.C., Loveland B.E. A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro. Eur. J. Immunol. 26:1996;578-585.
4. Colburn M.D., Quinones-Baldrich W.J., Gelabert H.A., Nowara H., Moore W.S. Standardization of skeletal muscle ischemic injury. J. Surg. Res. 52:1992;309-313.
5. Flower R.J. Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol. 94:1988;987-1015.
6. Grace P.A. Ischaemia-reperfusion injury. Br. J. Surg. 81:1994;637-647.
7. Hickey M.J., Hurley J.V., Angel M.F., O'Brien B.McC. The response of the rectus femoris muscle in the rabbit to ischemia and reperfusion. J. Surg. Res. 53:1992;369-377.
8. Jurell G., Fredholm B.B. Early changes in ATP and cAMP levels in experimental critical skin flaps. Acta Physiol. Scand. 113:1981;33-36.
9. Kerrigan C.L., Stotland M.A. Ischemia reperfusion injury: A review. Microsurgery. 14:1993;165-175.
10. Knox L.K., Stewart A.G., Hayward P.G., Morrison W.A. Nitric oxide synthase inhibitors improve skin flap survival in the rat. Microsurgery. 15:1994;708-711.
11. Korthuis R.J., Granger D.N., Townsley M.I., Taylor A.E. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ. Res. 57:1985;599-609.
12. Labbe R., Lindsay T., Gatley R., Romaschin A., Mickle D., Wilson G., Houte S., Walker P. Quatitation of postischemic muscle necrosis: Histochemical and radioisotope techniques. J. Surg. Res. 44:1988;45-53.
13. Lepore D.A., Knight K.R., Stewart A.G., Riccio M., Morrison W.A. Platelet-activating factor (PAF) receptor antagonist WEB 2170 improves the survival of ischaemic skeletal muscle. Ann. Acad. Med. Singapore. 24 (Suppl.):1995;63S-67S.
14. McCall T.B., Palmer R.M.J., Moncada S. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur. J. Immunol. 21:1991;2523-2527.
15. McCord J.M. Oxygen-derived free radicals in post-ischemic tissue injury. N. Engl. J. Med. 312:1985;159-163.
16. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-141.
17. Phan L.H., Hickey M.J., Niazi Z.B.M., Stewart A.G. Nitric oxide inhibitor, nitroiminoethyl-L-ornithine, reduces ischemia-reperfusion injury in rabbit skeletal muscle. Microsurgery. 15:1994;703-707.
18. Seekamp A., Warren J.S., Remick D.G., Till G.O., Ward P.A. Requirements for tumor necrosis factor-α and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am. J. Pathol. 143:1993;453-463.
19. Seekamp A., Mulligan M.S., Till G.O., Ward P.A. Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury. Am. J. Pathol. 142:1993;1217-1226.
20. Smith K.J., Grisham M.B., Granger D.N., Korthuis R.J. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am. J. Physiol. 256:1989;4789-4793.
21. Southan G.J., Szabo C., Thiemermann C. Isothioureas: Potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br. J. Pharmacol. 114:1995;510-516.
22. Strock P.E., Majno G. Vascular responses to tourniquet ischemia. Surg. Gynecol. Obstet. 129:1969;309-318.
23. Strock P.E., Majno G. Microvascular changes in acutely ischemic rat muscle. Surg. Gynecol. Obstet. 129:1969;1213-1224.
24. Suzuki K., Ota N., Sasagawa S., Sakatani T., Fujikara T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal. Biochem. 132:1983;345-352.
25. Vary T.C., Angelakos E.T., Schaffer S.W. Relationship between adenine nucleotide metabolism and irreversible ischemic tissue damage in isolated perfused rat heart. Circ. Res. 45:1979;218-225.
26. Weisman H.F., Bartow T., Leppo M.K., Marsh H.C. Jr., Carson G.R., Concino M.F., Boyle M.P., Ronx K.H., Weisfeldt M.L., Fearon D.T. Soluble human complement receptor type 1: In vivo inhibition of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 249:1990;146-151.
27. Williams T.J., Yarwood H. Effect of glucocorticoids on microvascular permeability. Am. Rev. Respir. Dis. 141:1990;S39-S43.
28. Yarwood H., Noushargh S., Brain S., Williams T.J. Effect of dexamethasone on neutrophil accumulation and oedema formation in rabbit skin: An investigation of site of action. Br. J. Pharmacol. 108:1993;959-966.
29. Zhang, B., Knight, K.R., Dowsing, B., Guida, E., Phan, L.H., Hickey, M.J., Morrison, W.A., Stewart, A.G., 1997. The timing of dexamethasone or the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester, is critical for effective treatment of ischaemia-reperfusion injury to skeletal muscle. Clin Sci, in press.